Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
about
Update in the medical therapy of Cushing's diseasePituitary disorders and osteoporosisThe Treatment of Cushing's Disease.Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesThe risks of overlooking the diagnosis of secreting pituitary adenomasPortal Vein Thrombosis in the Setting of Newly Diagnosed Cushing's SyndromeCHADS 2 Scores in the Prediction of Major Adverse Cardiovascular Events in Patients with Cushing's SyndromeCortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas.Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing’s syndromeThe hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome.Death in pediatric Cushing syndrome is uncommon but still occurs.Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone.Cushing's syndrome: epidemiology and developments in disease management.Cushing's syndrome in childhood: update on genetics, treatment, and outcomes.Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extensionTreatment of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelineResidual manifestations of hypercortisolemia following surgical treatment in a patient with Cushing syndrome.Association of Renal Resistive Index, Renal Pulsatility Index, Systemic Hypertension, and Albuminuria with Survival in Dogs with Pituitary-Dependent Hyperadrenocorticism.Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated.Current best practice in the management of patients after pituitary surgery.Managing Cushing's disease: the state of the art.Cardio-metabolic consequences of glucocorticoid replacement: relevance of ultradian signalling.Clinical and biochemical manifestations of Cushing's.Cushing's syndrome: an update on current pharmacotherapy and future directions.Dilated Cardiomyopathy Revealing Cushing Disease: A Case Report and Literature Review.Volumetric magnetic resonance imaging analysis in patients with short-term remission of Cushing's disease.A genetic and molecular update on adrenocortical causes of Cushing syndrome.The chronic syndromes after previous treatment of pituitary tumours.Cushing's syndrome and pregnancy outcomes: a systematic review of published cases.BclI Glucocorticoid Receptor Polymorphism in Relation to Arterial Stiffening and Cardiac Structure and Function: The Hoorn and CODAM Studies.Recommendations of the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism for the diagnosis of Cushing's disease in Brazil.A venous thromboembolism risk assessment model for patients with Cushing's syndrome.Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetes.Activation and regulation of endogenous retroviral genes in the human pituitary gland and related endocrine tumours.Acute mesenteric ischemia and hepatic infarction after treatment of ectopic Cushing's syndrome.Dimethoxy-etomidate: A Non-hypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.Downregulation of cholesteryl ester transfer protein by glucocorticoids: a randomised study on HDL.Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.A lack of day-by-day variability in blood pressure in a Cushing's disease patient.
P2860
Q26865203-96E16426-3A86-44A3-BC55-DD157A53F756Q27008465-C2C773C8-5D31-43C7-BDFB-C1B2E535C7FBQ27010590-675F754B-BE36-4D6E-8F0A-83B561A510ADQ28076013-E0ACF506-F3E2-405F-AFCC-605C6C4C318EQ28076665-FFCA107C-D9BF-487D-94A3-179F0B94461FQ33605606-6F048F98-5770-4C73-AFA1-F33B44ABCF9DQ33914689-D10AAD5C-90BD-4323-AD44-02885642BD27Q34628416-77DA620C-BA44-44B4-9D62-43FBF73FDD1BQ34743189-72108831-9F94-476E-B825-6FD137385DE4Q35126105-F380E326-5310-4A84-81B4-53C47D76161CQ35208064-E1E0DA39-D037-460A-88BD-EB1C11EECBAFQ35209046-B5D47BA7-FE1F-4A3C-A543-DA6668D5A239Q35441693-AF3486F7-2E93-47AA-9C1E-48E19E8EADCAQ35531889-612D2441-8974-49E3-9CFF-EDA83A1501BEQ35555316-46B73758-C139-4DF2-B0C3-BEEC2C9A4C6FQ35823679-9567EA92-52DD-446B-81DF-A1941CCD60A4Q35916555-1907E6B9-E804-4855-B17F-36586895E7E2Q36000914-AC2AB002-50CB-49DC-8B9F-998FAEB5E616Q37000125-6B8DE9A3-9543-4536-BE04-904298E7CBACQ37601888-80F5F31D-6791-4F67-B330-A640E8FCC6E2Q37718163-C033F3A7-9C29-4C41-B596-398638910307Q38177740-FE0C28B6-237B-4E43-9198-A1B94CA4676EQ38194625-8FF5F805-ECAE-4DB4-ADA5-C95603417A54Q38311631-721BEE36-1490-462B-B06D-87E70509E9E5Q38541695-2296AA91-51FC-47B9-9CCE-5E96D43FF940Q38637130-697B6149-D43B-4F2D-9636-5C29D346B34FQ38764585-BCA81552-A984-45CF-9D80-1CFED128FE0BQ38769185-EE996CA2-87FA-4268-A92D-A93A6FD2F264Q38853092-AD72544D-C446-40C1-B8B7-174718B8887FQ38972540-1C522D35-B2C0-4B7D-9155-B8AF02FF20EFQ40376882-7E8D2DC9-2D6C-4154-B3D4-AC947B21A963Q40632126-CB757D58-1DDF-4DB6-860A-68CB99DFEC7BQ40795123-603A4822-FB2C-435F-920E-1B726CDEB483Q40827243-EC354C28-A2B1-41A6-B8CA-4E22A77D2157Q42230994-0F8B815A-E4A5-423F-8546-CD3265F106CAQ42289866-A9DFFE45-C2C2-444C-A93D-75E3581BE33DQ47224599-A7EBBF6D-434D-4548-A067-F437A111D262Q47364550-DA8EC573-D8D3-4166-9CB8-21DBEDFFED7EQ47675105-A8B22A1B-B23D-4FA0-896F-E62795BD166AQ48088647-8F11B2E0-24D2-4632-8429-685B0F460751
P2860
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
@en
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
@nl
type
label
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
@en
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
@nl
prefLabel
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
@en
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
@nl
P2093
P50
P356
P1476
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
@en
P2093
Erzsébet Horváth-Puhó
Henrik Toft Sørensen
Jan P Vandenbroucke
Suzanne C Cannegieter
P304
P356
10.1210/JC.2012-3582
P407
P50
P577
2013-03-26T00:00:00Z